Health-Related Quality of Life in Gay Men With Localized Prostate Cancer

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
David Latini, Baylor College of Medicine Identifier:
First received: January 23, 2009
Last updated: July 24, 2013
Last verified: July 2013

RATIONALE: Gathering information about prostate cancer, treatment, and quality of life from gay men with prostate cancer may help doctors plan the best treatment.

PURPOSE: This clinical trial is collecting information about health-related quality of life from gay men with localized prostate cancer.

Prostate Cancer

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional

Resource links provided by NLM:

Further study details as provided by Baylor College of Medicine:

Primary Outcome Measures:
  • Effect of disease factors and treatment factors on subjective well-being [ Time Frame: Cross-sectional retrospective study, one timepoint ] [ Designated as safety issue: No ]
  • Effect of disease factors and treatment factors on illness intrusiveness [ Time Frame: Cross-sectional retrospective study, one timepoint ] [ Designated as safety issue: No ]
  • Effect of psychosocial factors on subjective well-being [ Time Frame: Cross-sectional retrospective study, one timepoint ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: August 2008
Estimated Study Completion Date: December 2015
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Detailed Description:


  • To enroll 200 gay men with localized prostate cancer in a cross-sectional study of prostate cancer outcomes.
  • To complete an R01 application using pilot data collected from these patients.
  • To complete manuscripts describing the factors that influence quality of life and treatment satisfaction in these patients.

OUTLINE: Patients complete a web-based survey about their disease (biopsy Gleason score, PSA at diagnosis, and T-stage), treatment (treatment type, time since treatment, and use of healthcare services [e.g., oral medications for erectile dysfunction]), symptom distress, and psychosocial factors (ethnicity, health literacy, level of social support, communication with provider, relationship status, and communication with partner) that affect their health-related quality of life. The data will be used to provide the information necessary to tailor an existing prostate cancer survivorship intervention to address the specific needs of gay men with prostate cancer.


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Convenience sample contacted via Internet



  • Diagnosis of localized prostate cancer

    • No advanced disease
  • Self-identified as gay


  • Able to complete an online questionnaire
  • Able to speak and understand English


  • Not specified
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00828633

United States, Texas
Dan L. Duncan Cancer Center at Baylor College of Medicine
Houston, Texas, United States, 77030
Veterans Affairs Medical Center - Houston
Houston, Texas, United States, 77030
Canada, Ontario
Ryerson University
Toronto, Ontario, Canada, M5B 2K3
Sponsors and Collaborators
Baylor College of Medicine
Principal Investigator: David M. Latini, PhD Baylor College of Medicine
  More Information

Additional Information:
No publications provided

Responsible Party: David Latini, Adjunct Assistant Professor of Urology, Baylor College of Medicine Identifier: NCT00828633     History of Changes
Other Study ID Numbers: CDR0000600597, BCM-H-21892
Study First Received: January 23, 2009
Last Updated: July 24, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Baylor College of Medicine:
stage I prostate cancer
stage II prostate cancer

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms processed this record on June 28, 2015